Genetic variations in VEGF and VEGFR2 and glioblastoma outcome

Journal of Neuro-Oncology

Volumn 104, Issue 2, 2011, Pages 523-527

  Sjostrom S ^a   Wibom, C ^a   Andersson, U ^a   Brannstrom T ^b   Broholm, H ^c   Johansen, C ^d   Collatz Laier, H ^e   Liu, Y ^f   Bondy, M ^f   Henriksson, R ^a   Melin, B ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c Rigshospitalet   (Denmark)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e SLAGELSE HOSPITAL   (Denmark)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Association study; Glioblastoma outcome; Survival; Vascular endothelial growth factor (VEGF); Vascular endothelial growth factor receptor (VEGFR)

Indexed keywords

LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER SURVIVAL; CONTROLLED STUDY; DENMARK; FALSE POSITIVE RESULT; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; YOUNG ADULT;

EID: 80052615267     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0504-2     Document Type: Article

References (15)

1. DA Bhowmick Z Zhuang SD Wait RJ Weil 2004 A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease Cancer Res 64 1220 1223 14973082 10.1158/0008-5472.CAN-03-3137 1:CAS:528:DC%2BD2cXhtleisLs%3D (Pubitemid 38235584)
2. E Vauleon N Auger A Benouaich-Amiel F Laigle-Donadey G Kaloshi J Lejeune JY Delattre J Thillet M Sanson 2007 The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma Cancer Genet Cytogenet 172 33 37 17175377 10.1016/j.cancergencyto.2006.07.013 1:CAS:528:DC%2BD28Xhtlarsr3F (Pubitemid 44920265)
3. S Sjostrom U Andersson Y Liu T Brannstrom H Broholm C Johansen H Collatz-Laier R Henriksson M Bondy B Melin 2010 Genetic variations in EGF and EGFR and glioblastoma outcome Neuro Onco 12 815 821 10.1093/neuonc/noq018
4. ME Scheurer E Amirian Y Cao MR Gilbert KD Aldape DG Kornguth R El-Zein ML Bondy 2008 Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma Clin Cancer Res 14 6640 6646 18927306 10.1158/1078-0432.CCR-07-4681 1:CAS:528:DC%2BD1cXht1Kgur%2FJ
5. D Krex B Klink C Hartmann A von Deimling T Pietsch M Simon M Sabel JP Steinbach O Heese G Reifenberger M Weller G Schackert 2007 Long-term survival with glioblastoma multiforme Brain 130 2596 2606 17785346 10.1093/brain/awm204 (Pubitemid 47511715)
6. P Knizetova J Ehrmann A Hlobilkova I Vancova O Kalita Z Kolar J Bartek 2008 Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay Cell Cycle 7 2553 2561 18719373 10.4161/cc.7.16.6442 1:CAS:528:DC%2BD1cXht1elsbjI
7. RD Oehring M Miletic MM Valter T Pietsch J Neumann R Fimmers U Schlegel 1999 Vascular endothelial growth factor (VEGF) in astrocytic gliomas-a prognostic factor? J Neuro-Oncol 45 117 125 10.1023/A:1006333005563 1:STN:280:DC%2BD3c3jvV2qug%3D%3D (Pubitemid 30197725)
8. TD Solberg J Nearman J Mullins S Li J Baranowska-Kortylewicz 2008 Correlation between tumor growth delay and expression of cancer and host VEGF, VEGFR2, and osteopontin in response to radiotherapy Int J Rad Oncol Biol Phys 72 918 926 10.1016/j.ijrobp.2008.06.1925 1:CAS:528:DC%2BD1cXhtFOgt7rN
9. U Andersson P Osterman S Sjostrom C Johansen R Henriksson T Brannstrom H Broholm HC Christensen A Ahlbom A Auvinen M Feychting S Lonn A Kiuru A Swerdlow M Schoemaker G Roos B Malmer 2009 MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome Int J Cancer 125 968 972 19405125 10.1002/ijc.24363 1:CAS:528:DC%2BD1MXnsFeltbw%3D
10. E Cardis L Richardson I Deltour B Armstrong M Feychting C Johansen M Kilkenny P McKinney B Modan S Sadetzki J Schuz A Swerdlow M Vrijheid A Auvinen G Berg M Blettner J Bowman J Brown A Chetrit HC Christensen A Cook S Hepworth G Giles M Hours I Iavarone A Jarus-Hakak L Klaeboe D Krewski S Lagorio S Lonn S Mann M McBride K Muir L Nadon ME Parent N Pearce T Salminen M Schoemaker B Schlehofer J Siemiatycki M Taki T Takebayashi T Tynes M van Tongeren P Vecchia J Wiart A Woodward N Yamaguchi 2007 The Interphone study: design, epidemiological methods, and description of the study population Eur J Epidemiol 22 647 664 17636416 10.1007/s10654-007-9152-z (Pubitemid 47402436)
11. S Shete FJ Hosking LB Robertson SE Dobbins M Sanson B Malmer M Simon Y Marie B Boisselier JY Delattre K Hoang-Xuan S El Hallani A Idbaih D Zelenika U Andersson R Henriksson AT Bergenheim M Feychting S Lonn A Ahlbom J Schramm M Linnebank K Hemminki R Kumar SJ Hepworth A Price G Armstrong Y Liu X Gu R Yu C Lau M Schoemaker K Muir A Swerdlow M Lathrop M Bondy RS Houlston 2009 Genome-wide association study identifies five susceptibility loci for glioma Nat Genet 41 899 904 19578367 10.1038/ng.407 1:CAS:528:DC%2BD1MXotVCltrw%3D
12. Q Jin K Hemminki K Enquist P Lenner E Grzybowska R Klaes R Henriksson B Chen J Pamula W Pekala H Zientek J Rogozinska-Szczepka B Utracka-Hutka G Hallmans A Forsti 2005 Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis Clin Cancer Res 11 3647 3653 15897560 10.1158/1078-0432.CCR-04-1803 1:CAS:528:DC%2BD2MXktFyrsbs%3D (Pubitemid 40685580)
13. JG Kim YS Chae SK Sohn YY Cho JH Moon JY Park SW Jeon IT Lee GS Choi SH Jun 2008 Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer Clin Cancer Res 14 62 66 18172253 10.1158/1078-0432.CCR-07-1537 1:CAS:528:DC%2BD1cXoslOn (Pubitemid 351377979)
14. HS Phillips S Kharbanda R Chen WF Forrest RH Soriano TD Wu A Misra JM Nigro H Colman L Soroceanu PM Williams Z Modrusan BG Feuerstein K Aldape 2006 Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis Cancer Cell 9 157 173 16530701 10.1016/j.ccr.2006.02.019 1:CAS:528:DC%2BD28XivFWjtL4%3D (Pubitemid 43357943)
15. R Henriksson P Bergstrom M Johansson M Sandstrom 2009 Enigma of a rapid introduction of antiangiogenic therapy with bevacizumab in glioblastoma: a new era in the treatment of malignant brain tumours? Acta Oncol 48 6 8 18932097 10.1080/02841860802468112